These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31994785)

  • 21. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
    Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
    BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uric acid relates to dopamine transporter availability in Parkinson's disease.
    Moccia M; Pappatà S; Erro R; Picillo M; Vitale C; Amboni M; Longo K; Palladino R; Barone P; Pellecchia MT
    Acta Neurol Scand; 2015 Feb; 131(2):127-31. PubMed ID: 25288358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
    Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
    J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    Huertas I; Jesús S; Lojo JA; García-Gómez FJ; Cáceres-Redondo MT; Oropesa-Ruiz JM; Carrillo F; Vargas-Gonzalez L; Martín Rodríguez JF; Gómez-Garre P; García-Solís D; Mir P
    PLoS One; 2017; 12(3):e0174644. PubMed ID: 28358829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
    Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
    Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal Dopamine Denervation Impairs Gait Automaticity in Drug-Naïve Parkinson's Disease Patients.
    Hirata K; Hattori T; Kina S; Chen Q; Ohara M; Yokota T
    Mov Disord; 2020 Jun; 35(6):1037-1045. PubMed ID: 32163636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".
    Schwarzschild MA; Marek K; Eberly S; Oakes D; Shoulson I; Jennings D; Seibyl J; Ascherio A;
    Mov Disord; 2011 Aug; 26(10):1864-8. PubMed ID: 21538532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obstructive Sleep Apnea and Striatal Dopamine Availability in Parkinson's Disease.
    Oh YS; Kim JS; Lyoo CH; Kim H
    Mov Disord; 2023 Jun; 38(6):1068-1076. PubMed ID: 37046390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
    Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
    Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Camacho V; Lopez-Mora DA; Pagonabarraga J; Kulisevsky J
    Neurobiol Aging; 2021 Jan; 97():120-128. PubMed ID: 33212336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
    Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
    Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients.
    Rossi C; Genovesi D; Marzullo P; Giorgetti A; Filidei E; Corsini GU; Bonuccelli U; Ceravolo R
    Clin Neuropharmacol; 2017; 40(1):34-36. PubMed ID: 27941527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
    Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort.
    Kim R; Lee J; Kim Y; Kim A; Jang M; Kim HJ; Jeon B; Kang UJ; Fahn S
    Parkinsonism Relat Disord; 2018 Jun; 51():49-54. PubMed ID: 29523394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum.
    Labrador-Espinosa MA; Grothe MJ; Macías-García D; Jesús S; Adarmes-Gómez A; Muñoz-Delgado L; Fernández-Rodríguez P; Martín-Rodríguez JF; Huertas I; García-Solís D; Mir P
    Clin Nucl Med; 2021 Jun; 46(6):e296-e306. PubMed ID: 33782308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.